Zacks Investment Research on MSN
Recursion Pharmaceuticals (RXRX) falls more steeply than broader market: What investors ...
In the latest close session, Recursion Pharmaceuticals (RXRX) was down 1.87% at $2.89. This change lagged the S&P 500's daily loss of 0.19%. At the same time, the Dow lost 0.59%, and the tech-heavy ...
Detailed price information for Amneal Pharmaceuticals Inc (AMRX-Q) from The Globe and Mail including charting and trades.
近年来,AI制药裹挟着资本市场的追捧,行业内部风起云涌,掀起投资热潮。 然而,业内一种现象值得关注:接踵而至的临床失败为AI新药研发行业浇下了一盆冷水,这直接导致部分AI创新药制药公司放弃手中管线,转型做起了CRO服务。
Writer's new AI harness study cuts enterprise token spend by 38% and cost per task by 41% across six foundation models, ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果